Patents Assigned to DIAGEN D.O.O.
  • Stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
    Patent number: 9850282
    Abstract: Stable pentadecapeptide salts of formula (I): (I) SEQ?ID?NO?1 Gly?Glu?Pro?Pro?Pro?Gly?Lys?Pro?Ala?Asp?Asp?Ala 1???????????????5???????????????????10??????????? Gly?Leu?Val?· n?BAA ????????15 wherein n means 1, 2 or 3, and BAA means basic amino acid, a process for the preparation thereof, a process for the use thereof for the manufacture of pharmaceutical formulations in liquid and solid form and a use thereof for prevention, protection in treatment of diseases and disease conditions and for the preparation of formulations for use as food supplements are described.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: December 26, 2017
    Assignee: DIAGEN D.O.O.
    Inventor: Rudolf Rucman
  • NEW STABLE PENTADECAPEPTIDE SALTS, A PROCESS FOR PREPARATION THEREOF, A USE THEREOF IN THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS AND A USE THEREOF IN THERAPY
    Publication number: 20160068572
    Abstract: The present invention discloses new stable pentadecapeptide salts of formula (I): (I) SEQ?ID?NO?1 Gly?Glu?Pro?Pro?Pro?Gly?Lys?Pro?Ala?Asp?Asp?Ala 1???????????????5???????????????????10??????????? Gly?Leu?Val?· n?BAA ????????15 wherein n means 1, 2 or 3, and BAA means basic amino acid, a process for the preparation thereof, a process for the use thereof for the manufacture of pharmaceutical formulations in liquid and solid form and a use thereof for prevention, protection in treatment of diseases and disease conditions and for the preparation of formulations for use as food supplements.
    Type: Application
    Filed: May 9, 2013
    Publication date: March 10, 2016
    Applicant: DIAGEN D.O.O.
    Inventor: Rudolf RUCMAN